An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder

NCT07693608 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Methamphetamine Use Disorder
Cocaine Use Disorder
Stimulant Use Disorders

Interventions

DRUG: Tirzepatide

Sponsor

University of Texas Southwestern Medical Center